Stock Information
Halozyme Therapeutics Inc (HALO)
Ticker Symbol: HALO
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $13,069.97 mil
Piotroski score: 7
PE Ratio: 31.11
EPS (TTM): 3.35
Revenue (TTM): $13.73 M
Dividend Yield: N/A
ROE: 180.63%
Latest News
-
Why Women-Run Companies Deserve a Place in Your Portfolio
Thu, Sep 24, 2026 4:42 PM
-
Add These 4 GARP Stocks to Your Portfolio to Receive Handsome Returns
Wed, Sep 23, 2026 2:31 PM
-
If You Invested $1000 in Halozyme Therapeutics a Decade Ago, This is How Much It'd Be Worth Now
Wed, Sep 23, 2026 12:30 PM
-
$1000 Invested In Halozyme Therapeutics 15 Years Ago Would Be Worth This Much Today
Wed, Sep 23, 2026 10:30 AM
-
Strength Seen in Halozyme Therapeutics (HALO): Can Its 3.3% Jump Turn into More Strength?
Wed, Sep 23, 2026 9:30 AM
-
1 Cash-Producing Stock to Target This Week and 2 We Question
Tue, Sep 22, 2026 9:17 AM
-
Halozyme (HALO) Just Made A $1.3B Bet On Itself
Tue, Sep 22, 2026 2:57 AM
Key Financials
Financial data not available
